These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 33800944)

  • 41. miRNA levels are associated with body mass index in endometrial cancer and may have implications for therapy.
    Ravegnini G; Gorini F; Coada CA; De Leo A; de Biase D; Di Costanzo S; De Crescenzo E; Coschina E; Monesmith S; Bernante P; Garelli S; Balsamo F; Hrelia P; De Iaco P; Angelini S; Perrone AM
    Cancer Sci; 2024 Mar; 115(3):883-893. PubMed ID: 38196275
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Epigenetic alteration and microRNA dysregulation in cancer.
    Suzuki H; Maruyama R; Yamamoto E; Kai M
    Front Genet; 2013 Dec; 4():258. PubMed ID: 24348513
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Epigenetic inactivation of DAPK1, p14ARF, mir-34a and -34b/c in acute promyelocytic leukaemia.
    Ng HY; Wan TS; So CC; Chim CS
    J Clin Pathol; 2014 Jul; 67(7):626-31. PubMed ID: 24811488
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Methylation-associated silencing of MicroRNA-335 contributes tumor cell invasion and migration by interacting with RASA1 in gastric cancer.
    Li Z; Li D; Zhang G; Xiong J; Jie Z; Cheng H; Cao Y; Jiang M; Lin L; Le Z; Tan S; Zou W; Gong B; Lin S; Yang K
    Am J Cancer Res; 2014; 4(6):648-62. PubMed ID: 25520857
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Aberrant MicroRNA Expression in Patients With Endometrial Cancer.
    Montagnana M; Benati M; Danese E; Giudici S; Perfranceschi M; Ruzzenenete O; Salvagno GL; Bassi A; Gelati M; Paviati E; Guidi GC; Franchi M; Lippi G
    Int J Gynecol Cancer; 2017 Mar; 27(3):459-466. PubMed ID: 28129244
    [TBL] [Abstract][Full Text] [Related]  

  • 46. miR-196b targets c-myc and Bcl-2 expression, inhibits proliferation and induces apoptosis in endometriotic stromal cells.
    Abe W; Nasu K; Nakada C; Kawano Y; Moriyama M; Narahara H
    Hum Reprod; 2013 Mar; 28(3):750-61. PubMed ID: 23293219
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Genome-wide pharmacologic unmasking identifies tumor suppressive microRNAs in multiple myeloma.
    Bi C; Chung TH; Huang G; Zhou J; Yan J; Ahmann GJ; Fonseca R; Chng WJ
    Oncotarget; 2015 Sep; 6(28):26508-18. PubMed ID: 26164366
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [MicroRNA expression signature profile and its clinical significance in endometrioid carcinoma].
    Wang Y; Adila S; Zhang X; Dong Y; Li W; Zhou M; Li T
    Zhonghua Bing Li Xue Za Zhi; 2014 Feb; 43(2):88-94. PubMed ID: 24742567
    [TBL] [Abstract][Full Text] [Related]  

  • 49. MicroRNA expression profiling in endometriosis-associated infertility and its relationship with endometrial receptivity evaluated by ultrasound.
    Xu X; Li Z; Liu J; Yu S; Wei Z
    J Xray Sci Technol; 2017; 25(3):523-532. PubMed ID: 28506024
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Methylation deregulation of miRNA promoters identifies miR124-2 as a survival biomarker in Breast Cancer in very young women.
    Oltra SS; Peña-Chilet M; Vidal-Tomas V; Flower K; Martinez MT; Alonso E; Burgues O; Lluch A; Flanagan JM; Ribas G
    Sci Rep; 2018 Sep; 8(1):14373. PubMed ID: 30258192
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Expression and DNA methylation alterations of seven cancer-associated 3p genes and their predicted regulator miRNAs (miR-129-2, miR-9-1) in breast and ovarian cancers.
    Pronina IV; Loginov VI; Burdennyy AM; Fridman MV; Kazubskaya TP; Dmitriev AA; Braga EA
    Gene; 2016 Jan; 576(1 Pt 3):483-91. PubMed ID: 26519551
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Role of miRNAs in the Regulation of Endometrial Cancer Invasiveness and Metastasis-A Systematic Review.
    Klicka K; Grzywa TM; Klinke A; Mielniczuk A; Włodarski PK
    Cancers (Basel); 2021 Jul; 13(14):. PubMed ID: 34298609
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Genome-wide microRNA expression profiling in idiopathic non-obstructive azoospermia: significant up-regulation of miR-141, miR-429 and miR-7-1-3p.
    Wu W; Qin Y; Li Z; Dong J; Dai J; Lu C; Guo X; Zhao Y; Zhu Y; Zhang W; Hang B; Sha J; Shen H; Xia Y; Hu Z; Wang X
    Hum Reprod; 2013 Jul; 28(7):1827-36. PubMed ID: 23559187
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Microsatellite instability: an update.
    Yamamoto H; Imai K
    Arch Toxicol; 2015 Jun; 89(6):899-921. PubMed ID: 25701956
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Epigenetic silencing of the tumor suppressor microRNA Hsa-miR-124a regulates CDK6 expression and confers a poor prognosis in acute lymphoblastic leukemia.
    Agirre X; Vilas-Zornoza A; Jiménez-Velasco A; Martin-Subero JI; Cordeu L; Gárate L; San José-Eneriz E; Abizanda G; Rodríguez-Otero P; Fortes P; Rifón J; Bandrés E; Calasanz MJ; Martín V; Heiniger A; Torres A; Siebert R; Román-Gomez J; Prósper F
    Cancer Res; 2009 May; 69(10):4443-53. PubMed ID: 19435910
    [TBL] [Abstract][Full Text] [Related]  

  • 56. MicroRNAs: predictors and modifiers of chemo- and radiotherapy in different tumour types.
    Hummel R; Hussey DJ; Haier J
    Eur J Cancer; 2010 Jan; 46(2):298-311. PubMed ID: 19948396
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Genome-wide profiling of chromatin signatures reveals epigenetic regulation of MicroRNA genes in colorectal cancer.
    Suzuki H; Takatsuka S; Akashi H; Yamamoto E; Nojima M; Maruyama R; Kai M; Yamano HO; Sasaki Y; Tokino T; Shinomura Y; Imai K; Toyota M
    Cancer Res; 2011 Sep; 71(17):5646-58. PubMed ID: 21734013
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Epigenetic analysis of sporadic and Lynch-associated ovarian cancers reveals histology-specific patterns of DNA methylation.
    Niskakoski A; Kaur S; Staff S; Renkonen-Sinisalo L; Lassus H; Järvinen HJ; Mecklin JP; Bützow R; Peltomäki P
    Epigenetics; 2014 Dec; 9(12):1577-87. PubMed ID: 25625843
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Tumor Suppressive mir-148a Is Epigenetically Inactivated in Classical Hodgkin Lymphoma.
    Paczkowska J; Janiszewska J; Bein J; Schneider M; Bednarek K; Ustaszewski A; Hartmann S; Hansmann ML; Giefing M
    Cells; 2020 Oct; 9(10):. PubMed ID: 33066457
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Alterations of epigenetics and microRNA in hepatocellular carcinoma.
    Saito Y; Hibino S; Saito H
    Hepatol Res; 2014 Jan; 44(1):31-42. PubMed ID: 23617364
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.